Clinical Trial Update: STaph Aureus Resistance-Treat Early and Repeat (STAR-TER) [Phase 2]

View source ↗

Summary

Phase 2 trial STAR-TER evaluating early and repeat treatment for Staphylococcus aureus in cystic fibrosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED